Home     Events     CD/Documentation     Training     About Us     Contact Us     Help     Your Basket  
The SMi Group
  
 
  Advanced Search
  User Log-In / Register
Events Home Page
Events Calendar
Venue Information
Accommodation
Speaker Opportunities
Marketing Opportunities
Sponsors & Exhibitions
Supplementary Info...
The CPD Certification Service
 
SMi is a member of
the CPD service
 
smi conferences - pharmaceuticals - events
Conferences Executive Briefings Masterclasses Search Events Other Sectors
Overview Programme Associated Events Sponsors Supporters Register Now
Add to Basket   Fax Order Form   Sponsorship/Exhibition Enquiry   Send to a Friend  
Controlled Release
 

associated eventsControlled release formulations: Patent strategies and opportunities for generic and biosimilar product development

overview

The controlled release of a pharmaceutical active can be a vital tool in ensuring the safety and efficacy of a new or existing treatment. Developing new methods of controlled release is important to prolong the duration of action, can help to minimise adverse reactions and maximise efficacy as well as being an effective way of increasing a drug's lifespan.

SMi's 7th Controlled Release conference will provide you with the latest updates in this area, including controlled release development strategies, practical issues in developing controlled release therapeutics and information on the latest advances in delivery methods.

 

 
 

Key topics to be addressed at the conference include:

  • The application of advanced science & technology to develop controlled release dosage forms
  • Controlled Release - the role of intellectual property in maintaining and growing market share
  • Controlled release in chronic diseases
  • Overcoming the blood brain barrier
  • Modified release multiparticulates 
  • Hot melt extrusion: How to enhance dissolution rate by solid dispersions
  • Developing novel inhaled controlled release therapeutics 

 

Feedback from previous delegates includes:

"Very good - Good programme, good venue. A very successful meeting." Senior Representative, IPSEN

"Good balanced panel of speakers" Senior Rep, ESTEVE

"SMi conferences are always well organised and good topics for discussion" Senior Rep, Genzyme

 

This two day conference will allow you to:

  • Identify opportunities for portfolio development
  • Discover new strategies for developing controlled release products
  • Hear from some of the leading organisations in the field
  • Network and transfer knowledge with fellow senior drug development experts
  • Establish relationships with new clients and suppliers
  • Assess your activities against those leading the way
 

This event will be chaired by:

Dr Ian Wilding, Special Professor, School of Pharmacy, Nottingham University & President, Ian Wilding Associates Limited
  Professor Howard Stevens, Emeritus Professor of Drug Delivery, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde

 

 

  • Dr Paul Ashton, President & Ceo, pSivida 
  • Professor Gregor Cevc, Chief Executive Officer, IDEA AG
  • Alan Johnson, Partner, Bristows
  • Dr Thomas Keller, Director - Biophysical Sensors & Nanomaterials PCD, GlaxoSmithKline
  • Dr Vitaliy Khutoryanskiy, Lecturer in Pharmaceutics, University of Reading
  • Dr Roger Kravtzoff, Director of Clinical and Preclinical Development, Flamel Technologies
  • Dr Andrew Lewis, Operations Director, Critical Pharmaceuticals
  • Dr Mario Maio, Head of Formulation and Process Development, Merck
  • Dr Hassan Mohammad, Principal Scientist, Mundipharma International 
  • Gerben Moolhuizen, Chief Business Officer, OctoPlus
  • Dr Joseph P. Reo, Research Fellow, Schering Plough Consumer Healthcare
  • Dr Andreas Schatzlein, Reader in Cancer Pharmacology, The School of Pharmacy, University of London
  • Dr Peter Scholes, VP Pharmaceutical Sciences, Quotient Clinical Ltd
  • Professor Howard Stevens, Emeritus Professor of Drug Delivery, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde
  • Dr Jens Uhlemann, Head of Product Design & Nanotechnology, Bayer Technology Services
  • Professor Ian Wilding, Professor, Institute of Pharmaceutical Sciences, Nottingham University & President, Ian Wilding Associates Limited
  • Dr Katie Amssoms, Senior Scientist, Tibotec
  • Dr Gurjit Bajwa, Principal Scientist, Pfizer 
 

 

All those responsible for research, clinical development and business development of controlled release products, including:
  • Heads of Drug Development
  • Heads of Business Development
  • Directors of Regulatory and Technical Affairs
  • Directors of Product Development
  • Directors of R&D
  • Operations Directors
  • Chief Scientific Officers
  • Principal Scientists, Product Development
  • VP, Technology Development
 

  Organisations represented at our previous Controlled Release conference have included:

 
  • Abbott GmbH & Co KG
  • Akzo Nobel
  • AstraZeneca
  • BASF
  • Baxter
  • Bayer
  • Bristol-Myers Squibb
  • BTG plc
  • Celltech
  • Cephalon Inc
  • Colorcon Ltd
  • Ferring Pharmaceuticals
  • Flamel Technologies
  • Genzyme Pharmaceuticals
  • Glaxo Smith Kline
  • Merck Sharp & Dohme Ltd
  • Napp Laboratories
  • Nektar Therapeutics
  • Novartis
  • Sanofi-Aventis
  • Teva Pharmaceutical
  • UCB-Celltech

   

 

 

 

Crowne Plaza St James London
 
45-51 Buckingham Gate
London 
SW1E 6AF
 
Tel: +44 (0) 207 834 6655
Fax: +44 (0) 207 834 6307
 
www.london.crowneplaza.com

Crowne Plaza St James London is a traditional deluxe hotel right in the heart of the city, perfectly situated for all your business and leisure needs.  In the heart of Westminster, it is just a stones throw away from Buckingham Palace, The Houses of Parliament, the London Eye and Victoria Station.


The hotel boasts three excellent restaurants. Bistro 51 with British and European cuisine, the Michelin Starred Indian restaurant Quilon serving south coastal Indian food and Bank Westminster with a modern British menu.  A beautiful, award-winning, courtyard garden surrounds the Victorian buildings of the Crowne Plaza London St James - a peaceful oasis in the centre of London.
 
Nearest train stations:
• Victoria Station, 7 minutes’ walk
• Waterloo Station, 10 minutes by car

Underground stations
• St James’s Park, 5 minutes’ walk (District and Circle lines)
• Victoria Station, 7 minutes' walk (Victoria, District and Circle lines)

From St. James's Park Underground Station to the Hotel
Take the main St James’s Park exit and turn left into Petty France Street.
Continue Straight down for 200 yards and at the end turn left into Buckingham Gate
SMi discounted rates include Continental Breakfast & VAT
£ 205.63 / Standard room / night for single occupancy
£ 229.13 Executive  room / night for single occupancy

Book your accommodation at SMi discounted rates by calling us on +44 (0)870 9090 713, sending a fax to +44 (0)870 9090 714 or emailing hotels@smi-online.co.uk.
 

 

 

 


associated events
Controlled release formulations: Patent strategies and opportunities for generic and biosimilar product development

27th April 2010, Crowne Plaza Hotel - St James, London.

sponsors & supporting publications/associations:
Alrise Bachem Quotient Clinical Limited   
Admet.net Anti Infective Drug News Biocompare CanBiotech
ClinicalTrials.net CombiChem Drug Delivery Insight Eu-Pharmagate
European Life Science Journal Expert Review of Anti Cancer Therapy Genericsweb GoingToMeet.com
Inpharm Molecular Diagnostics ONdrugDelivery Pharma Marketing News
Pharmcast.com Pharmiweb Piribo Report Buyer
Thomson Pharma       
costs and discounts

Conference Registration

Conference Registration - Event Registration                £1,299.00    Add to Basket
Conference Registration - Attend Day 1 Only                £999.00    Add to Basket
Conference Registration - Attend Day 2 Only                £999.00    Add to Basket
Conference Registration - Promotional Literature Distribution                £999.00    Add to Basket

Executive Briefing Registration

Executive Briefing - Controlled release formulations: Patent strategies and opportunities for generic and biosimilar product development                £499.00    Add to Basket

Conference Documentation

28/04/2010 Controlled Release, Conference Documentation - PDF Documentation on CD ROM, Single User License                £499.00    Add to Basket
28/04/2010 Controlled Release, Conference Documentation - PDF Documentation on CD ROM, Site License                £1,497.00    Add to Basket